Viewing Study NCT01113658


Ignite Creation Date: 2025-12-25 @ 12:03 AM
Ignite Modification Date: 2025-12-25 @ 10:01 PM
Study NCT ID: NCT01113658
Status: WITHDRAWN
Last Update Posted: 2022-08-01
First Post: 2010-04-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Evaluation of the SNaP Wound Care System
Sponsor: 3M
Organization:

Study Overview

Official Title: Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System
Status: WITHDRAWN
Status Verified Date: 2022-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: The study was terminated by Spiracur (original sponsor). Efforts were made to contact the PI/study team members, but were unsuccessful.
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to assess the efficacy of design improvements of the Spiracur SNaP Wound Care System. This study prospectively evaluates the safety and efficacy of current and new design iterations of components of the FDA-cleared Spiracur SNaP Wound Care System in order to optimize safety, efficacy, and system performance.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: